Tag: Health care industry

Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Posted on By Admin No Comments on Weight loss drugs could be a gamechanger for women with a common hormonal disorder

Wegovy injection pens arranged in Waterbury, Vermont, US, on Monday, April 28, 2025. Shelby Knowles | Bloomberg | Getty Images For well over a decade, Grace Hamilton, 27, experienced hair loss, heavy periods, infrequent menstrual cycles, mental health issues and difficulty losing weight without knowing why. It wasn’t until 2023 when she was diagnosed with…

Read More “Weight loss drugs could be a gamechanger for women with a common hormonal disorder” »

Health

Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

Posted on By Admin No Comments on Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals

An aerial view of Valley Health Hampshire Memorial Hospital on June 17, 2025 in Romney, W.V. Ricky Carioti | The Washington Post | Getty Images President Donald Trump‘s “big beautiful bill” would make sweeping changes to U.S. health care, leaving millions of vulnerable Americans without health insurance and threatening the hospitals and centers that provide…

Read More “Medicaid cuts in Trump’s ‘big beautiful bill’ will leave millions uninsured, threaten rural hospitals” »

Health

Anne Wojcicki to buy back 23andMe and its data for $305 million

Posted on By Admin No Comments on Anne Wojcicki to buy back 23andMe and its data for $305 million

23andMe founder Anne Wojcicki speaks during a House Committee on Oversight and Government Reform hearing in Washington, D.C., on June 10, 2025. Andrew Harnik | Getty Images Anne Wojcicki, the co-founder and former CEO of 23andMe, has regained control over the embattled genetic testing company after her new nonprofit, TTAM Research Institute, outbid Regeneron Pharmaceuticals,…

Read More “Anne Wojcicki to buy back 23andMe and its data for $305 million” »

Health

Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access

Posted on By Admin No Comments on Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access

A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. A wave of outrage is sweeping the scientific and medical world after Health and Human Services Secretary Robert F. Kennedy Jr.’s decision to stop recommending routine Covid-19…

Read More “Healthy Returns: RFK Jr.’s Covid vaccine recommendation change could threaten health, access” »

Health

Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

Posted on By Admin No Comments on Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know 

President Donald Trump, joined by National Institutes of Health (NIH) Director Jay Bhattacharya, speaks during a press conference in the Roosevelt Room of the White House on May 12, 2025, in Washington, DC. Andrew Harnik | Getty Images News | Getty Images President Donald Trump on Monday moved forward with a plan to lower U.S….

Read More “Trump wants to slash U.S. drug prices with ‘most favored nation’ policy – here’s what to know ” »

Health

Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

Posted on By Admin No Comments on Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro

An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant’s weight loss drug Zepbound and its diabetes treatment Mounjaro, the company’s latest attempt to crack down on…

Read More “Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro” »

Health

Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

Posted on By Admin No Comments on Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound

A combination image shows an injection pen of Zepbound, Eli Lilly’s weight loss drug, and boxes of Wegovy, made by Novo Nordisk.  Reuters President Donald Trump on Friday dropped a Biden administration proposal to have Medicare cover obesity drugs, including popular but costly GLP-1 treatments such as Novo Nordisk‘s Wegovy and Eli Lilly‘s Zepbound. But the Centers…

Read More “Trump drops Biden’s proposal for Medicare to cover obesity drugs like Wegovy and Zepbound” »

Health

Healthy Returns: What to know about the U.S. measles outbreak

Posted on By Admin No Comments on Healthy Returns: What to know about the U.S. measles outbreak

MMR vaccine administer prep is pictured during a drive at the City of Lubbock Health Department in Lubbock, Texas, U.S. Feb. 27, 2025. Annie Rice | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions….

Read More “Healthy Returns: What to know about the U.S. measles outbreak” »

Health

A child dies of measles in West Texas outbreak

Posted on By Admin No Comments on A child dies of measles in West Texas outbreak

A school-age child has died of measles in West Texas, the first death from the disease in a decade in the United States. The child had not been vaccinated against measles, according to the city of Lubbock’s health department. The death, confirmed by Katherine Wells, the Lubbock health department’s director of public health, is part…

Read More “A child dies of measles in West Texas outbreak” »

Health

Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients

Posted on By Admin No Comments on Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients

Hims & Hers is facing scrutiny from lawmakers over an advertisement for its weight loss offerings that’s slated to run during the Super Bowl on Sunday. Sens. Dick Durbin, D-Ill., and Roger Marshall, R-Kan., wrote a letter to the U.S. Food and Drug Administration on Friday expressing concerns over an “upcoming advertisement” that “risks misleading…

Read More “Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients” »

Health